UNSPSC 51102831: Chloramphenicol/hydrocortisone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102831 Chloramphenicol/hydrocortisone is a Commodity code representing a narrow pharmaceutical product line, though recent state and local activity under this specific code shows minimal traction. The most recent opportunities posted under this code involve related pharmaceutical products purchased through bulk warehouse and emergency response supply channels, including antibiotic tablets and naloxone kits procured for public health stockpiling and community health support.

Activity under the code is sparse and geographically limited. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (IFB 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets with an initial 12-month term and two renewal options. Separately, Seminole County, Florida released an IFB (IFB60459723LAS) posted June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building, though this opportunity sits outside the code's stated pharmaceutical scope. State departments and county health and emergency management agencies are the primary issuing bodies. The code does not show sustained recent activity sufficient to indicate material procurement volume or a robust vendor pipeline in state and local markets.